CT
Celea TherapeuticsClinical-stage biotech developing deupirfenidone, a deuterated pirfenidone-derived drug for idiopathic pulmonary fibrosis, spun out of PureTech Health.
4 Pulse stories
TM
Tenon MedicalTenon Medical develops the Catamaran, a minimally invasive titanium implant system for sacroiliac joint fusion to treat lower back pain.
1 Pulse story
Total Raised
$180M
Celea TherapeuticsTenon Medical
Last ValuationNot disclosed
Biotech
Sector
Biotech
2025
Founded
2012
Boston, MA
HQ
Los Gatos, California
Private
Status
Public (TNON)
Celea Therapeutics investors
RA Capital ManagementLeaps by BayerPureTech Health
Tenon Medical investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for Celea Therapeutics and Tenon Medical.